Paving the way for tomorrow's cures
Pathway is a life science real estate platform developed by King Street Properties to give companies the space they need to research, develop, and manufacture their drugs without compromise. We remove the real estate obstacles that companies face when considering their drug development options, allowing them to focus on their quest to cure disease.
Pathway offers two time-savings options which can shorten occupancy by 8-24 months.
With Pathway, all the time-consuming up-front work is done. Tenants can select either speculatively constructed based building packages or fully permitted, shovel-ready pad sites.
Why King Street
Design Informed by Experience
We've specialized in life science real estate for almost 20 years, building lasting partnerships across the industry and helping companies navigate the real estate process.
Well-Capitalized Agility
Our long-term outlook, flexible approach, and ample access to capital allow us to quickly and creatively construct a space that meets your research, development, and biomanufacturing requirements.
Placemaking for Science
We've always been committed to creating places that perfectly balance functionality and design. Our state-of-the-art cgmp manufacturing facilities provide the R&D and production framework you need while offering an environment your employees will love coming to every day.
Pathway Statistics
2.8M SF
Existing portfolio
4.3M SF
Development pipeline
7.1M SF
Total portfolio
28
Life science properties across Boston, NYC, California, & Research Triangle
Some of our biomanufacturing customers
